Yizhe Wang - Oct 29, 2021 Form 3 Insider Report for LianBio (LIAN)

Role
Chief Executive Officer, Director
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Oct 29, 2021
Transactions value $
$0
Form type
3
Date filed
10/29/2021, 06:16 PM
Next filing
Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIAN Stock Option (Right to Buy) Oct 29, 2021 Ordinary Shares 1.94M $6.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/2 of the shares underlying the option shall vest and become exercisable on May 17, 2022; the remaining 1/2 shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on May 17, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney